Cargando…

Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population

OBJECTIVE: The main aim of this study was to investigate the association of polymorphisms in long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) with the risk of esophageal squamous cell carcinoma (ESCC) in a Chinese population. METHODS: A total of 245 ESCC patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yan, Shao, Na, Yang, Wenjing, Wang, Jianbo, Cheng, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452823/
https://www.ncbi.nlm.nih.gov/pubmed/31040692
http://dx.doi.org/10.2147/OTT.S191155
_version_ 1783409353422798848
author Qu, Yan
Shao, Na
Yang, Wenjing
Wang, Jianbo
Cheng, Yufeng
author_facet Qu, Yan
Shao, Na
Yang, Wenjing
Wang, Jianbo
Cheng, Yufeng
author_sort Qu, Yan
collection PubMed
description OBJECTIVE: The main aim of this study was to investigate the association of polymorphisms in long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) with the risk of esophageal squamous cell carcinoma (ESCC) in a Chinese population. METHODS: A total of 245 ESCC patients and 490 gender- and age-matched cancer-free controls were genotyped for four tag single nucleotide polymorphisms (SNPs) of MALAT1 (rs3200401 C > T, rs1122709 C > G, rs664589 C > G, and rs619586 A > G). Statistical analyses including chi-squared test and logistic regression were performed to identify the association between the tag SNPs and risk of ESCC, and false discovery rate (FDR) <25% was applied to adjust for multiple comparisons. RESULTS: We found that rs3200401 C > T polymorphism of MALAT1 was significantly associated with increased risk of ESCC (CT vs CC: adjusted OR =1.59, 95% CI =1.07–2.35, P=0.021; TT vs CC: adjusted OR =2.27, 95% CI =1.04–4.96, P=0.039; dominant model [CT+TT vs CC]: adjusted OR =1.68, 95% CI =1.16–2.43, P=0.006). In the stratified analysis, rs3200401 TT and CT/TT genotypes were associated with increased risk of ESCC compared with CC genotype in subgroup of never drinking (TT vs CC: adjusted OR =2.34, 95% CI =1.02–5.34, P=0.044; CT/TT vs CC: adjusted OR =1.52, 95% CI =1.02–2.26, P=0.041). However, compared with AA genotype, MALAT1 rs619586 GG was associated with decreased risk of ESCC in ever drinking subgroup (GG vs AA: adjusted OR =0.38, 95% CI =0.15–0.99, P=0.049). The results remained significant after FDR adjustment (FDR value <0.25) except for the comparison between rs619586 GG and AA genotype in ever drinking subgroup. CONCLUSION: Taken together, our findings proposed that polymorphism rs3200401 C > T in MALAT1 gene is associated with increased risk of ESCC. Since the association between rs619586 A > G polymorphism and ESCC risk was not significant after FDR adjustment, there was a minor possibility that rs619586 A > G might be a protective factor for ESCC.
format Online
Article
Text
id pubmed-6452823
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64528232019-04-30 Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population Qu, Yan Shao, Na Yang, Wenjing Wang, Jianbo Cheng, Yufeng Onco Targets Ther Original Research OBJECTIVE: The main aim of this study was to investigate the association of polymorphisms in long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) with the risk of esophageal squamous cell carcinoma (ESCC) in a Chinese population. METHODS: A total of 245 ESCC patients and 490 gender- and age-matched cancer-free controls were genotyped for four tag single nucleotide polymorphisms (SNPs) of MALAT1 (rs3200401 C > T, rs1122709 C > G, rs664589 C > G, and rs619586 A > G). Statistical analyses including chi-squared test and logistic regression were performed to identify the association between the tag SNPs and risk of ESCC, and false discovery rate (FDR) <25% was applied to adjust for multiple comparisons. RESULTS: We found that rs3200401 C > T polymorphism of MALAT1 was significantly associated with increased risk of ESCC (CT vs CC: adjusted OR =1.59, 95% CI =1.07–2.35, P=0.021; TT vs CC: adjusted OR =2.27, 95% CI =1.04–4.96, P=0.039; dominant model [CT+TT vs CC]: adjusted OR =1.68, 95% CI =1.16–2.43, P=0.006). In the stratified analysis, rs3200401 TT and CT/TT genotypes were associated with increased risk of ESCC compared with CC genotype in subgroup of never drinking (TT vs CC: adjusted OR =2.34, 95% CI =1.02–5.34, P=0.044; CT/TT vs CC: adjusted OR =1.52, 95% CI =1.02–2.26, P=0.041). However, compared with AA genotype, MALAT1 rs619586 GG was associated with decreased risk of ESCC in ever drinking subgroup (GG vs AA: adjusted OR =0.38, 95% CI =0.15–0.99, P=0.049). The results remained significant after FDR adjustment (FDR value <0.25) except for the comparison between rs619586 GG and AA genotype in ever drinking subgroup. CONCLUSION: Taken together, our findings proposed that polymorphism rs3200401 C > T in MALAT1 gene is associated with increased risk of ESCC. Since the association between rs619586 A > G polymorphism and ESCC risk was not significant after FDR adjustment, there was a minor possibility that rs619586 A > G might be a protective factor for ESCC. Dove Medical Press 2019-04-03 /pmc/articles/PMC6452823/ /pubmed/31040692 http://dx.doi.org/10.2147/OTT.S191155 Text en © 2019 Qu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Qu, Yan
Shao, Na
Yang, Wenjing
Wang, Jianbo
Cheng, Yufeng
Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population
title Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population
title_full Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population
title_fullStr Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population
title_full_unstemmed Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population
title_short Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population
title_sort association of polymorphisms in malat1 with the risk of esophageal squamous cell carcinoma in a chinese population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452823/
https://www.ncbi.nlm.nih.gov/pubmed/31040692
http://dx.doi.org/10.2147/OTT.S191155
work_keys_str_mv AT quyan associationofpolymorphismsinmalat1withtheriskofesophagealsquamouscellcarcinomainachinesepopulation
AT shaona associationofpolymorphismsinmalat1withtheriskofesophagealsquamouscellcarcinomainachinesepopulation
AT yangwenjing associationofpolymorphismsinmalat1withtheriskofesophagealsquamouscellcarcinomainachinesepopulation
AT wangjianbo associationofpolymorphismsinmalat1withtheriskofesophagealsquamouscellcarcinomainachinesepopulation
AT chengyufeng associationofpolymorphismsinmalat1withtheriskofesophagealsquamouscellcarcinomainachinesepopulation